prtx007
primmune therapeutics,immune therapeutics
['prtx007', 'immune therap']
today we announced new clinical data at #aacr23 from our first-in-human, phase 1 study evaluating primmune s lead candidate, prtx007. primmune cmo curtis scribner, m.d., is presenting the data today, april 18, from 9am to 12:30pm et in orlando, florida: 